{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:23:30Z","timestamp":1691727810481},"posted":{"date-parts":[[2023,4,24]]},"group-title":"In Review","reference-count":44,"publisher":"Research Square Platform LLC","license":[{"start":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T00:00:00Z","timestamp":1682294400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2023,4,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n        <jats:p><jats:bold>Background<\/jats:bold> Although the literature suggests that medication-assisted treatment (MAT) is an effective treatment for opioid use disorder, limited studies have assessed the prevalence or the association between MAT use and sexual identity, mental health, or substance use disorder among a nationally representative sample. We assessed the prevalence and association of opioid MAT use between sexual identity, depressive disorder symptoms, alcohol use dependence, and marijuana use dependence in the United States.<jats:bold>Methods<\/jats:bold> We used the 2019 National Survey on Drug Use and Health public-use data on adults aged 18\u201364 years <jats:italic>(N<\/jats:italic>\u2009=\u200938,841) to conduct a weighted multivariable logistic regression analysis.<jats:bold>Results<\/jats:bold> A total of 4.80% and 2.32% of the population identified as bisexual and lesbian\/gay, respectively. About 0.31% (612,750 people) of the population reported receiving opioid MAT, 3.73% had alcohol use dependence, 1.42% had marijuana use dependence, and 9.13% had major depressive episode (MDE) symptoms. Of those who had received opioid MAT, 0.57% were bisexuals and 1.07% were lesbians\/gays, 0.65% were people with alcohol use dependence, 2.32% with marijuana use dependence, and 1.59% with MDE symptoms. Lesbian\/gay individuals were more likely to receive opioid MAT (AOR\u2009=\u20093.43, 95% CI\u2009=\u20091.42, 8.25) compared to heterosexual individuals. The odds were higher for people with marijuana use dependence (AOR\u2009=\u20093.44, 95% CI\u2009=\u20091.47, 8.06) and MDE symptoms (AOR\u2009=\u20095.22, 95% CI\u2009=\u20093.46, 7.89) than their counterparts.<jats:bold>Conclusions<\/jats:bold> In this study, sexual minorities, people with MDE symptoms, and those dependent on marijuana use were more likely to receive opioid MAT, suggesting the need to investigate further opioid use disorder symptoms and their risk factors among these populations.<\/jats:p>","DOI":"10.21203\/rs.3.rs-2837899\/v1","type":"posted-content","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T08:55:49Z","timestamp":1682326549000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of receiving opioid medication-assisted treatment with sexual identity and mental health\/substance use disorder symptoms in a nationally representative sample of adults"],"prefix":"10.21203","author":[{"given":"David","family":"Adzrago","sequence":"first","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabrielle S","family":"Evans","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuelle M","family":"Dias","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Kwentua","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grace Elizabeth","family":"White","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Wilkerson","sequence":"additional","affiliation":[{"name":"The University of Texas Health Science Center at Houston (UTHealth)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8761","reference":[{"key":"ref1","volume-title":"Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56)","author":"Substance Abuse and Mental Health Services Administration","year":"2021","unstructured":"Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: Results from the 2020 National Survey on Drug Use and Health (HHS Publication No. PEP21-07-01-003, NSDUH Series H-56). Rockville, MD: Center for Behavioral Health Statistics and Quality; 2021. Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/data\/."},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention. (2021)Opioid basics. https:\/\/www.cdc.gov\/opioids\/basics\/index.html."},{"key":"ref3","unstructured":"National Institute on Drug Abuse. (2021) Opioids. https:\/\/www.drugabuse.gov\/drug-topics\/opioids."},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/ejp.1337","article-title":"Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990\u20132016","volume":"23","author":"Bosetti C","year":"2019","unstructured":"Bosetti C, Santucci C, Radrezza S, Erthal J, Berterame S, Corli O. Trends in the consumption of opioids for the treatment of severe pain in Europe, 1990\u20132016. Eur J Pain. 2019;23(4):697\u2013707.","journal-title":"Eur J Pain"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-3-540-33823-9_2","author":"Z\u00f6llner C","year":"2006","unstructured":"Z\u00f6llner C, Stein C. (2006) Opioids. Analgesia 31\u201363.","journal-title":"Analgesia"},{"key":"ref6","author":"Dydyk AM","year":"2022","unstructured":"Dydyk AM, Jain NK, Gupta M. (2022) Opioid use disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK553166\/."},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. (2013) Diagnostic and statistical manual of mental disorders (5th ed.). https:\/\/doi.org\/10.1176\/appi.books.9780890425596.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref8","unstructured":"American Psychiatric Association. (2018) Opioid use disorder. https:\/\/www.psychiatry.org\/patients-families\/addiction\/opioid-use-disorder."},{"issue":"1","key":"ref9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12916-018-1058-y","article-title":"Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study","volume":"16","author":"Chang HY","year":"2018","unstructured":"Chang HY, Kharrazi H, Bodycombe D, Weiner JP, Alexander GC. Healthcare costs and utilization associated with high-risk prescription opioid use: a retrospective cohort study. BMC Med. 2018;16(1):1\u20131. https:\/\/doi.org\/10.1186\/s12916-018-1058-y.","journal-title":"BMC Med"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.amepre.2018.07.032","article-title":"Sexual orientation disparities in prescription opioid misuse among US adults","volume":"56","author":"Duncan DT","year":"2019","unstructured":"Duncan DT, Zweig S, Hambrick HR, Palamar JJ. Sexual orientation disparities in prescription opioid misuse among US adults. Am J Prev. 2019;56(1):17\u201326. https:\/\/doi.org\/10.1016\/j.amepre.2018.07.032.","journal-title":"Am J Prev"},{"key":"ref11","first-page":"1","article-title":"Sexual orientation and estimates of adult substance use and mental health: results from the 2015 National Survey on Drug Use and Health","volume":"10","author":"Medley GL","year":"2016","unstructured":"Medley GL, Lipari RN, Bose J, Cribb DS, Kroutil LA, McHenry G. Sexual orientation and estimates of adult substance use and mental health: results from the 2015 National Survey on Drug Use and Health. NSDUH data review. 2016;10:1\u201354.","journal-title":"NSDUH data review"},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1080\/10550887.2012.694600","article-title":"Culturally competent substance abuse treatment with transgender persons","volume":"31","author":"Nuttbrock LA","year":"2012","unstructured":"Nuttbrock LA. Culturally competent substance abuse treatment with transgender persons. J Addict Dis. 2012;31(3):236\u201341. https:\/\/doi.org\/10.1080\/10550887.2012.694600.","journal-title":"J Addict Dis"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.drugalcdep.2014.11.023","article-title":"Prevalence and correlates of substance use among trans female youth ages 16\u201324 years in the San Francisco Bay Area","volume":"147","author":"Rowe C","year":"2015","unstructured":"Rowe C, Santos GM, McFarland W, Wilson EC. Prevalence and correlates of substance use among trans female youth ages 16\u201324 years in the San Francisco Bay Area. Drug Alcohol Depend. 2015;147:160\u20136. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.023.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1001\/jamapsychiatry.2020.3554","article-title":"Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis","volume":"78","author":"Rosoff DB","year":"2021","unstructured":"Rosoff DB, Smith GD, Lohoff FW. Prescription opioid use and risk for major depressive disorder and anxiety and stress-related disorders: a multivariable mendelian randomization analysis. JAMA Psychiatry. 2021;78(2):151\u201360. https:\/\/doi.org\/10.1001\/jamapsychiatry.2020.3554.","journal-title":"JAMA Psychiatry"},{"issue":"5","key":"ref15","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster LR","year":"2017","unstructured":"Webster LR. Risk factors for opioid-use disorder and overdose. Anesth Analg. 2017;125(5):1741\u20138. https:\/\/doi.org\/10.1213\/ANE.0000000000002496.","journal-title":"Anesth Analg"},{"key":"ref16","author":"Huang W","year":"2019","unstructured":"Huang W, Penaherrera EP, Desir DF, Gamarro DL, Cottrell J, Chu T, Chang SL. (2019) Bi-directional acceleration of alcohol use and opioid use disorder. J Stud Alcohol Drugs 236084.","journal-title":"J Stud Alcohol Drugs"},{"key":"ref17","author":"Hughes A","year":"2016","unstructured":"Hughes A, Williams MR, Lipari RN, Bose J, Copello EA, Kroutil LA. (2016) Prescription drug use and misuse in the United States: results from the 2015 National Survey on Drug Use and Health. NSDUH Data Review A1-A24. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR2-2015\/NSDUH-FFR2-2015.hm."},{"issue":"6","key":"ref18","doi-asserted-by":"publisher","first-page":"12855","DOI":"10.4088\/JCP.15m10386","article-title":"Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States","volume":"77","author":"Saha TD","year":"2016","unstructured":"Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, Huang B, Hasin DS. Nonmedical prescription opioid use and DSM-5 nonmedical prescription opioid use disorder in the United States. J Clin Psychiatry. 2016;77(6):12855. https:\/\/doi.org\/10.4088\/JCP.15m10386.","journal-title":"J Clin Psychiatry"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/acer.13797","author":"Saxon AJ","year":"2018","unstructured":"Saxon AJ. (2018) The unmet challenges of co-occurring alcohol and opioid use. Alcohol : Clin Exp Res (8), 1406\u20137.","journal-title":"Alcohol : Clin Exp Res"},{"issue":"7","key":"ref20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1111\/acer.13772","article-title":"Opioid misuse as a predictor of alcohol treatment outcomes in the combine study: mediation by medication adherence","volume":"42","author":"Witkiewitz K","year":"2018","unstructured":"Witkiewitz K, Votaw VR, Vowles KE, Kranzler HR. Opioid misuse as a predictor of alcohol treatment outcomes in the combine study: mediation by medication adherence. Alcohol : Clin Exp Res. 2018;42(7):1249\u201359.","journal-title":"Alcohol : Clin Exp Res"},{"issue":"1","key":"ref21","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis use and risk of prescription opioid use disorder in the United States","volume":"175","author":"Olfson M","year":"2018","unstructured":"Olfson M, Wall MM, Liu SM, Blanco C. Cannabis use and risk of prescription opioid use disorder in the United States. Am J Psychiatry. 2018;175(1):47\u201353. https:\/\/doi.org\/10.1176\/appi.ajp.2017.17040413.","journal-title":"Am J Psychiatry"},{"issue":"12","key":"ref22","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1038\/s41380-018-0094-5","article-title":"Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis","volume":"4","author":"Ma J","year":"2019","unstructured":"Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, Degenhardt L, Farrell M, Blow FC, Ilgen M, Shi J. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019;4(12):1868\u201383.","journal-title":"Mol Psychiatry"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/10550887.2012.694598","article-title":"Maintenance medication for opiate addiction: the foundation of recovery","volume":"31","author":"Bart G","year":"2012","unstructured":"Bart G. Maintenance medication for opiate addiction: the foundation of recovery. J Addict Dis. 2012;31(3):207\u201325.","journal-title":"J Addict Dis"},{"issue":"2","key":"ref24","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/HRP.0000000000000075","article-title":"Medication-assisted treatment of opioid use disorder: review of the evidence and future directions","volume":"23","author":"Connery HS","year":"2015","unstructured":"Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23(2):63\u201375. https:\/\/doi.org\/10.1097\/HRP.0000000000000075.","journal-title":"Harv Rev Psychiatry"},{"key":"ref25","unstructured":"Center for Behavioral Health Statistics and Quality. (2020) 2019 National Survey on Drug Use and Health public use file codebook. https:\/\/www.datafiles.samhsa.gov\/sites\/default\/files\/field-uploads-protected\/studies\/NSDUH-2019\/NSDUH-2019-datasets\/NSDUH-2019-DS0001\/NSDUH-2019-DS0001-info\/NSDUH-2019-DS0001-info-codebook.pdf."},{"key":"ref26","unstructured":"Substance Abuse and Mental Health Services Administration. (2020) Results from the 2019 National Survey on Drug Use and Health: detailed tables. Rockville, MD: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https:\/\/www.samhsa.gov\/data\/report\/2019-nsduh-detailed-tables."},{"key":"ref27","unstructured":"Harvard School of Medicine. (2005) National Comorbidity Survey (NCS). https:\/\/www.hcp.med.harvard.edu\/ncs\/."},{"key":"ref28","volume-title":"Study guide to DSM-IV-TR","author":"Fauman MA","year":"2002","unstructured":"Fauman MA. Study guide to DSM-IV-TR. American Psychiatric Pub; 2002. https:\/\/books.google.com\/books?hl=en&lr=&id=evvAhaPGqVQC&oi=fnd&pg=PP9&dq=Fauman+MA+(2002).+Study+guide+to+DSM-IV-TR,+American+Psychiatric+Publishing,+Inc.++++++&ots=aVreCWX6qY&sig=agNCaSYfXahlZHlPp4GucGPKrTc#v=onepage&q=Fauman%20MA%20(2002).%20Study%20guide%20to%20DSM-IV-TR%2C%20American%20Psychiatric%20Publishing%2C%20Inc.&f=false."},{"key":"ref29","volume-title":"Stata Statistical Software. Release 16.[software]","author":"StataCorp LL","year":"2021","unstructured":"StataCorp LL. Stata Statistical Software. Release 16.[software]. College Station, TX; 2021."},{"issue":"7","key":"ref30","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.18502\/ijph.v50i7.6626","article-title":"Evaluation of multiple imputation with large proportions of missing data: how much is too much?","volume":"50","author":"Lee JH","year":"2021","unstructured":"Lee JH, Huber JC Jr. Evaluation of multiple imputation with large proportions of missing data: how much is too much? Iran J Public Health. 2021;50(7):1372\u201380. https:\/\/doi.org\/10.18502\/ijph.v50i7.6626.","journal-title":"Iran J Public Health"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096228029900800102","article-title":"Multiple imputation: a primer","volume":"8","author":"Schafer JL","year":"1999","unstructured":"Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999;8(1):3\u201315.","journal-title":"Stat Methods Med Res"},{"issue":"2","key":"ref32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1213\/ANE.0000000000005593","article-title":"Multicollinearity in logistic regression models","volume":"133","author":"Bayman EO","year":"2021","unstructured":"Bayman EO, Dexter F. Multicollinearity in logistic regression models. Anesth Analg. 2021;133(2):362\u20135.","journal-title":"Anesth Analg"},{"issue":"7","key":"ref33","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1097\/AJP.0000000000000021","article-title":"The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription","volume":"30","author":"Edlund MJ","year":"2014","unstructured":"Edlund MJ, Martin BC, Russo JE, DeVries A, Braden JB, Sullivan MD. The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic non-cancer pain: the role of opioid prescription. Clin J Pain. 2014;30(7):557. https:\/\/doi.org\/10.1097\/AJP.0000000000000021.","journal-title":"Clin J Pain"},{"issue":"7","key":"ref34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/CHI.0b013e318172ef0ld","article-title":"Characterizing adolescent prescription misusers: a population-based study","volume":"47","author":"Schepis TS","year":"2008","unstructured":"Schepis TS, Krishnan-Sarin S. Characterizing adolescent prescription misusers: a population-based study. J Am Acad Child Adolesc Psychiatry. 2008;47(7):745\u201354. https:\/\/doi.org\/10.1097\/CHI.0b013e318172ef0ld.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"109135","DOI":"10.1016\/j.drugalcdep.2021.109135","article-title":"Co-occurring substance use and psychological distress among exclusive e-cigarette use and other tobacco use among sexual and gender minorities in Texas","volume":"229","author":"Adzrago D","year":"2021","unstructured":"Adzrago D, Tami-Maury I, Schick V, Wilkerson JM. Co-occurring substance use and psychological distress among exclusive e-cigarette use and other tobacco use among sexual and gender minorities in Texas. Drug Alcohol Depend. 2021;229:109135.","journal-title":"Drug Alcohol Depend"},{"issue":"1","key":"ref36","first-page":"7","article-title":"Opioid misuse among sexual and gender minorities in Texas: the most vulnerable populations","volume":"9","author":"Paola A","year":"2021","unstructured":"Di Paola A, McCurdy SA, Schick V, Wilkerson JM. Opioid misuse among sexual and gender minorities in Texas: the most vulnerable populations. J Addict Prev. 2021;9(1):7.","journal-title":"J Addict Prev"},{"issue":"8","key":"ref37","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2105\/AJPH.2017.303917","article-title":"Challenges and solutions to collecting sexual orientation and gender identity data","volume":"107","author":"Sell RL","year":"2017","unstructured":"Sell RL. Challenges and solutions to collecting sexual orientation and gender identity data. Am J Public Health. 2017;107(8):1212\u20134.","journal-title":"Am J Public Health"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"106327","DOI":"10.1016\/j.addbeh.2020.106327","article-title":"Covariates of hazardous alcohol use among sexual and gender minorities in Texas: identifying the most vulnerable","volume":"105","author":"Wilkerson JM","year":"2020","unstructured":"Wilkerson JM, Di Paola A, McCurdy S, Schick V. Covariates of hazardous alcohol use among sexual and gender minorities in Texas: identifying the most vulnerable. Addict Behav. 2020;105:106327.","journal-title":"Addict Behav"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.drugalcdep.2019.02.007","article-title":"A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions","volume":"197","author":"Ling S","year":"2019","unstructured":"Ling S, Mangaoil R, Cleverley K, Sproule B, Puts M. A systematic review of sex differences in treatment outcomes among people with opioid use disorder receiving buprenorphine maintenance versus other treatment conditions. Drug Alcohol Depend. 2019;197:168\u201382. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.02.007.","journal-title":"Drug Alcohol Depend"},{"issue":"10141","key":"ref40","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(18)31203-0","article-title":"Women and opioids: something different is happening here","volume":"392","author":"Mazure CM","year":"2018","unstructured":"Mazure CM, Fiellin DA. Women and opioids: something different is happening here. Lancet (London England). 2018;392(10141):9\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(18)31203-0.","journal-title":"Lancet (London England)"},{"issue":"1\u20132","key":"ref41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/jnr.23963","article-title":"Sex differences, gender and addiction","volume":"95","author":"Becker JB","year":"2017","unstructured":"Becker JB, McClellan ML, Reed BG. Sex differences, gender and addiction. J Neurosci Res. 2017;95(1\u20132):136\u201347.","journal-title":"J Neurosci Res"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00952990.2011.596982","article-title":"Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial","volume":"37","author":"Back SE","year":"2011","unstructured":"Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W. Comparative profiles of men and women with opioid dependence: results from a national multisite effectiveness trial. Am J Drug Alcohol Abuse. 2011;37(5):313\u201323.","journal-title":"Am J Drug Alcohol Abuse"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cpr.2017.10.012","article-title":"Sex and gender differences in substance use disorders","volume":"66","author":"McHugh RK","year":"2018","unstructured":"McHugh RK, Votaw VR, Sugarman DE, Greenfield SF. Sex and gender differences in substance use disorders. Clin Psychol Rev. 2018;66:12\u201323.","journal-title":"Clin Psychol Rev"},{"issue":"1","key":"ref44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence","volume":"45","author":"McHugh RK","year":"2013","unstructured":"McHugh RK, DeVito EE, Dodd D, Carroll KM, Potter JS, Greenfield SF, Connery HS, Weiss RD. Gender differences in a clinical trial for prescription opioid dependence. J Subst Abuse Treat. 2013;45(1):38\u201343.","journal-title":"J Subst Abuse Treat"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2837899\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2837899\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T00:13:22Z","timestamp":1691712802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-2837899\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,24]]},"references-count":44,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-2837899\/v1","relation":{},"subject":[],"published":{"date-parts":[[2023,4,24]]},"subtype":"preprint"}}